Reimbursement Challenges and Solutions with Molecular Biomarker Testing

Geoffrey R. Oxnard, MD; Lauren L. Ritterhouse, MD, PhD

Drs. Geoffrey Oxnard and Lauren Ritterhouse consider the current landscape of reimbursement for molecular biomarker testing, the need to run FDA-approved tests, and the role of CMS and local Medicare providers in testing reimbursement.

Related Videos

November 3, 2014

New Data on PV Studies

Listen as Dr. Mesa discusses exciting new data in polycythemia vera on studies on hydrea coming out of ASCO and ASH.Supported through funding from Incyte

January 20, 2016

Defining Cancer Stem Cells

Dr Gerson provides an overview of cancer stem cells.